Colchicine for Autoimmune and Subacute Thyroiditis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2026
Thyroiditis includes inflammatory thyroid disorders such as Hashimoto\'s thyroiditis and subacute thyroiditis. These conditions may cause thyroid pain, neck tenderness, elevated inflammatory markers, thyroid dysfunction, fatigue, and recurrence. Current management includes observation, symptomatic treatment, nonsteroidal anti-inflammatory drugs, and corticosteroids. Although corticosteroids may be effective, relapse after tapering and treatment-related adverse effects remain limitations. Colchicine is hypothesized to reduce inflammatory activity and may improve biochemical and clinical recovery. This study will evaluate the efficacy and safety of low-dose colchicine compared with corticosteroid therapy and supportive care in adults with autoimmune or subacute thyroiditis.
Epistemonikos ID: dcee4b2336eab6cde3ac8fcbcde7d15a78d80092
First added on: May 07, 2026